ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,615Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 15

$728K Total Retail Price of All Prescriptions

Rank: 2 out of 15

992 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 992 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

23% of this provider’s 992 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,345 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
HYDROCODONE-ACETAMINOPHEN 721 498 S3 1 1
LISINOPRIL 642 571 2 2
LEVOTHYROXINE SODIUM 563 415 3 4
SIMVASTATIN 556 488 4 3
OMEPRAZOLE 491 387 5 7
METOPROLOL TARTRATE 377 323 6 10
AMLODIPINE BESYLATE 365 333 7 5
ZOLPIDEM TARTRATE 348 283 8 12
METFORMIN HCL 327 295 9 6
FUROSEMIDE 306 256 10 8
GABAPENTIN 264 203 11 13
TERAZOSIN HCL 225 198 12 37
LOVASTATIN 220 175 13 14
ATENOLOL 220 169 13 9
ALENDRONATE SODIUM 204 182 15 20
ALLOPURINOL 186 141 16 21
CITALOPRAM HBR 157 98 17 29
TRAMADOL HCL 149 124 18 28
TAMSULOSIN HCL 146 137 19 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 140 20 23
AZITHROMYCIN 137 93 21 15
POTASSIUM CHLORIDE 136 116 22 25
WARFARIN SODIUM 131 120 23 31
PREDNISONE 131 111 23 30
OXYCODONE HCL-ACETAMINOPHEN 130 84 S2 25 33
HYDROCHLOROTHIAZIDE 128 119 26 11
RANITIDINE HCL 126 103 27 27
SERTRALINE HCL 126 79 27 45
DONEPEZIL HCL 120 114 29 59
NAMENDA 120 120 29 59
PRAVASTATIN SODIUM 110 94 31 16
GLYBURIDE 107 82 R 32 62
CIPROFLOXACIN HCL 102 88 33 40
BACLOFEN 101 61 34 50
CLOPIDOGREL 99 89 35 44
CARISOPRODOL 94 22 R 36 19
CARVEDILOL 93 78 37 24
TRAZODONE HCL 90 53 38 49
PANTOPRAZOLE SODIUM 88 75 39 53
CLONIDINE HCL 86 74 40 41
LOSARTAN POTASSIUM 86 85 40 17
PLAVIX 84 80 42 47
LANTUS 84 58 42 66
TESTOSTERONE CYPIONATE 83 55 S3 44 67
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 62 45 68
IBUPROFEN 82 60 45 55
DIGOXIN 81 81 47 69
OXYCODONE HCL 79 48 S2 48 18
SPIRONOLACTONE 78 60 49 43
OXYBUTYNIN CHLORIDE 77 64 50 70
LACTULOSE 76 60 51 71
ADVAIR DISKUS 74 56 52 48
FINASTERIDE 74 74 52 50
BENAZEPRIL HCL 70 54 54 72
OXYCODONE-ACETAMINOPHEN 70 35 S2 54 58
SPIRIVA 70 47 54 38
METOPROLOL SUCCINATE 64 63 57 26
LOSARTAN-HYDROCHLOROTHIAZIDE 61 41 58 46
ROPINIROLE HCL 60 36 59 77
LEVETIRACETAM 60 25 59 77
MORPHINE SULFATE ER 60 23 S2 59 39
ATORVASTATIN CALCIUM 60 55 59 22
ESTRADIOL 57 27 R 63 83
PROAIR HFA 55 44 64 55
NEXIUM 54 24 65 61
FLUNISOLIDE 51 39 66 90
TRIAMCINOLONE ACETONIDE 50 40 67 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.